Catalyst
Slingshot members are tracking this event:
Pfizer (PFE) Expects Decision From European Medicines Agency on IBRANCE + Endocrine Therapy for HR+/HER2- Metastatic Breast Cancer By End of November
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| PFE |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Nov 10, 2016
Occurred Source:
http://www.pfizer.com/news/press-release/press-release-detail/ibrance_palbociclib_receives_approval_in_european_union_for_the_treatment_of_women_with_hr_her2_metastatic_breast_cancer
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
European Medicines Agency, Ibrance, Endocrine Therapy, Hr+/her2- Metastatic Breast Cancer
